These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38724041)

  • 21. Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa.
    Eichstadt S; Barriga M; Ponakala A; Teng C; Nguyen NT; Siprashvili Z; Nazaroff J; Gorell ES; Chiou AS; Taylor L; Khuu P; Keene DR; Rieger K; Khosla RK; Furukawa LK; Lorenz HP; Marinkovich MP; Tang JY
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31578311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel and very rare causative variants in the COL7A1 gene of Vietnamese patients with recessive dystrophic epidermolysis bullosa revealed by whole-exome sequencing.
    Ma THT; Luong TLA; Hoang TL; Nguyen TTH; Vu TH; Tran VK; Nguyen DB; Trieu TS; Nguyen HH; Nong VH; Nguyen DT
    Mol Genet Genomic Med; 2021 Aug; 9(8):e1748. PubMed ID: 34286919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What do we learn from dystrophic epidermolysis bullosa, nails only? Idiopathic nail dystrophy may harbor a COL7A1 mutation as the underlying cause.
    Yang R; Duan Y; Kong Q; Li W; Xu J; Xia X; Sang H
    J Dermatol; 2020 Jul; 47(7):782-786. PubMed ID: 32396230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa.
    Cutlar L; Greiser U; Wang W
    Exp Dermatol; 2014 Jan; 23(1):1-6. PubMed ID: 24107073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A microinjected COL7A1-PAC vector restores synthesis of intact procollagen VII in a dystrophic epidermolysis bullosa keratinocyte cell line.
    Mecklenbeck S; Compton SH; Mejía JE; Cervini R; Hovnanian A; Bruckner-Tuderman L; Barrandon Y
    Hum Gene Ther; 2002 Sep; 13(13):1655-62. PubMed ID: 12228020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidermolysis Bullosa (EB) Acquisita in an Adult Patient with Previously Unrecognized Mild Dystrophic EB and Biallelic COL7A1 Mutations.
    Guerra L; Condorelli AG; Fortugno P; Calabresi V; Pedicelli C; Di Zenzo G; Castiglia D
    Acta Derm Venereol; 2018 Apr; 98(4):411-415. PubMed ID: 29182795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mild recessive dystrophic epidermolysis bullosa associated with two compound heterozygous COL7A1 mutations.
    von Bartenwerffer W; Has C; Arin MJ; Tantcheva-Poór I; Kreuter A; Kremer K; Arshah T; Hoffmann M; Eming SA; Kohlhase J; Krieg T; Bruckner-Tuderman L; Hartmann K
    Eur J Dermatol; 2011; 21(2):170-2. PubMed ID: 21382783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case report. Novel and recurrent COL7A1 mutations in Chinese patients with dystrophic epidermolysis bullosa pruriginosa.
    Zhu KJ; Zhu CY; Zhou Y; Fan YM
    Genet Mol Res; 2014 Sep; 13(3):7587-92. PubMed ID: 25222259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An incompletely penetrant novel mutation in COL7A1 causes epidermolysis bullosa pruriginosa and dominant dystrophic epidermolysis bullosa phenotypes in an extended kindred.
    Yang CS; Lu Y; Farhi A; Nelson-Williams C; Kashgarian M; Glusac EJ; Lifton RP; Antaya RJ; Choate KA
    Pediatr Dermatol; 2012; 29(6):725-31. PubMed ID: 22515571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanding the COL7A1 mutation database: novel and recurrent mutations and unusual genotype-phenotype constellations in 41 patients with dystrophic epidermolysis bullosa.
    Kern JS; Kohlhase J; Bruckner-Tuderman L; Has C
    J Invest Dermatol; 2006 May; 126(5):1006-12. PubMed ID: 16484981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Availability of mRNA Obtained from Peripheral Blood Mononuclear Cells for Testing Mutation Consequences in Dystrophic Epidermolysis Bullosa.
    Akasaka E; Nakano H; Sawamura D
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa.
    Perdoni C; Osborn MJ; Tolar J
    Transl Res; 2016 Feb; 168():50-58. PubMed ID: 26073463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-improving dystrophic epidermolysis bullosa: First report of clinical, molecular, and genetic characterization of five patients from Southeast Asia.
    Bishnoi P; Ng YZ; Wei H; Tan EC; Lunny DP; Wong XFCC; Kin Fon L; Gondokaryono SP; Diana IA; Common JEA; Koh MJA; Lane EB
    Am J Med Genet A; 2021 Feb; 185(2):625-630. PubMed ID: 33258232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector.
    Jacków J; Titeux M; Portier S; Charbonnier S; Ganier C; Gaucher S; Hovnanian A
    J Invest Dermatol; 2016 Jul; 136(7):1346-1354. PubMed ID: 26994967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seven novel COL7A1 mutations identified in patients with recessive dystrophic epidermolysis bullosa from Mexico.
    Saeidian AH; Youssefian L; Moreno Trevino MG; Fortuna G; Vahidnezhad H; Atanasova VS; Uitto J; Salas-Alanis JC; South AP
    Clin Exp Dermatol; 2018 Jul; 43(5):579-584. PubMed ID: 29473190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the functional consequences of targeted exon deletion in COL7A1 reveals prospects for dystrophic epidermolysis bullosa therapy.
    Bornert O; Kühl T; Bremer J; van den Akker PC; Pasmooij AM; Nyström A
    Mol Ther; 2016 Aug; 24(7):1302-11. PubMed ID: 27157667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late-onset inversa recessive dystrophic epidermolysis bullosa caused by glycine substitutions in collagen type VII.
    Leverkus M; Ambach A; Hoefeld-Fegeler M; Kohlhase J; Schmidt E; Schumann H; Has C; Gollnick H
    Br J Dermatol; 2011 May; 164(5):1104-6. PubMed ID: 21275939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibroblast-based cell therapy strategy for recessive dystrophic epidermolysis bullosa.
    Yan WF; Murrell DF
    Dermatol Clin; 2010 Apr; 28(2):367-70, xii. PubMed ID: 20447505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Case of Dominant Dystrophic Epidermolysis Bullosa with a G2043R Mutation in the Type VII Collagen Gene.
    Komatsu K; Yamaguchi S; Utsumi D; Yamamoto I; Takahashi K
    Acta Dermatovenerol Croat; 2020 Dec; 28(4):251-252. PubMed ID: 33835003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identical COL71A1 heterozygous mutations resulting in different dystrophic epidermolysis bullosa phenotypes.
    Knöpfel N; Noguera-Morel L; Hernández-Martin A; García-Martin A; García M; Mencía Á; Pedrero RM; de Lucas R; Escámez MJ; Torrelo A
    Pediatr Dermatol; 2018 Mar; 35(2):e94-e98. PubMed ID: 29272047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.